Abstract
The incidence of acute respiratory distress syndrome (ARDS) varies significantly from study to study, from 5.0 to 78.9 per 100,000 persons per year regardless of severity. Within each study, there is a trend toward higher incidence in less severe ARDS than more severe ARDS. Among patients admitted to ICU, 16–20% of patients under mechanical ventilation are diagnosed as ARDS.
ICU mortality among ARDS patients is between 30% and 49%, and hospital mortality is between 37% and 58% from data collected after the American–European Consensus Conference (AECC) definition. Some reports conclude that trends in mortality are declining, whereas some do that the mortality remains the same, at least after the AECC definition. The mortality of ARDS in randomized controlled studies is generally lower than that in observational studies. In this way, the epidemiology of ARDS is not relatively conclusive.
Risk factors for ARDS include pneumonia, sepsis, aspiration, and trauma as primary diseases; chronic alcohol abuse, cigarette smoking, air pollution, and hypoproteinemia as comorbidities. Interestingly, patients with diabetes have a lower risk of developing ARDS. Transfusion, especially from multiparous women, inadequate antimicrobial therapy, mechanical ventilation with injurious tidal volumes, and aspiration are hospital-based modifiable exposures. There is an interaction of factors as risk enhancement in the development of ARDS. Thus, evading as many risk factors as possible is essential when treating ARDS patients or those at risk.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Luhr OR, Antonsen K, Karlsson M, et al. The ARF study group: incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med. 1999;159:1849–61. https://doi.org/10.1164/ajrccm.159.6.9808136.
Bersten AD, Edibam C, Hunt T, et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med. 2002;165(4):443–8. https://doi.org/10.1164/ajrccm.165.4.2101124.
Brun-Buisson C, Minelli C, Bertolini G, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004;30:51–61. https://doi.org/10.1007/s00134-003-2022-6.
Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–93. https://doi.org/10.1056/NEJMoa050333.
Linko R, Okkonen M, Pettilä V, et al. FINNALI-study group. Acute respiratory failure in intensive care units. FINNALI: a prospective cohort study. Intensive Care Med. 2009;35(8):1352–61. https://doi.org/10.1007/s00134-009-1519-z.
Villar J, Blanco J, Añón JM, et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37:1932–41. https://doi.org/10.1007/s00134-011-2380-4.
Sigurdsson MI, Sigvaldason K, Gunnarsson TS, et al. Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand. 2013;57:37–45. https://doi.org/10.1111/aas.12001.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–33. https://doi.org/10.1001/jama.2012.5669.
Bellani G, Laffey JG, Pham T, et al. LUNG SAFE investigators; ESICM trials group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. https://doi.org/10.1001/jama.2016.0291.
Pham T, Rubenfeld GD. Fifty years of research in ARDS. The epidemiology of acute respiratory distress syndrome. A 50th birthday review. Am J Respir Crit Care Med. 2017;195:860–70. https://doi.org/10.1164/rccm.201609-1773CP.
Robinson BRH, Cotton BA, Pritts TA, et al. Application of the Berlin definition in PROMMTT patients: the impact of resuscitation on the incidence of hypoxemia. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S61–7. https://doi.org/10.1097/TA.0b013e31828fa408.
Howard BM, Kornblith LZ, Hendrickson CM, et al. Differences in degree, differences in kind: characterizing lung injury in trauma. J Trauma Acute Care Surg. 2015;78:735–41. https://doi.org/10.1097/TA.0000000000000583.
Moss M, Bucher B, Moore FA, et al. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA. 1996;275:50–4.
Moss M, Parsons PE, Steinberg KP, et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med. 2003;31:869–77. https://doi.org/10.1097/01.CCM.0000055389.64497.11.
Simou E, Leonardi-Bee J, Britton J. The effect of alcohol consumption on the risk of ARDS: a systematic review and meta-analysis. Chest. 2018;154:58–68. https://doi.org/10.1016/j.chest.2017.11.041.
Calfee CS, Matthay MA, Kangelaris KN, et al. Cigarette smoke exposure and the acute respiratory distress syndrome. Crit Care Med. 2015;43:1790–7. https://doi.org/10.1097/CCM.0000000000001089.
Ware LB, Zhiguo Zhao Z, Koyama T, et al. Long-term ozone exposure increases the risk of developing the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2016;193:1143–50. https://doi.org/10.1164/rccm.201507-1418OC.
Reilly JP, Zhao Z, Shashaty MGS, et al. Low to moderate air pollutant exposure and acute respiratory distress syndrome after severe trauma. Am J Respir Crit Care Med. 2019;199:62–70. https://doi.org/10.1164/rccm.201803-0435OC.
Mangialardi RJ, Martin GS, Bernard GR, et al. Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in sepsis study group. Crit Care Med. 2000;28:3137–45. https://doi.org/10.1097/00003246-200009000-00001.
McCallister JW, Adkins EJ, O'Brien JM Jr. Obesity and acute lung injury. Clin Chest Med. 2009;30(3):495–508, vii. https://doi.org/10.1016/j.ccm.2009.05.008.
Moss M, Guidot DM, Steinberg KP, et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med. 2000;28:2187–92. https://doi.org/10.1097/00003246-200007000-00001.
Gong MN, Thompson BT, Williams P, et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005;33:1191–8. https://doi.org/10.1097/01.CCM.0000165566.82925.14.
Iscimen R, Cartin-Ceba R, Yilmaz M, et al. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med. 2008;36:1518–22. https://doi.org/10.1097/CCM.0b013e31816fc2c0.
Honiden S, Gong MN. Diabetes, insulin, and development of acute lung injury. Crit Care Med. 2009;37:2455–64. https://doi.org/10.1097/CCM.0b013e3181a0fea5.
Boyle AJ, Madotto F, Laffey JG, et al. Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database. Crit Care. 2018;22:268. https://doi.org/10.1186/s13054-018-2158-y.
Ahmed AH, Litell JM, Malinchoc M, et al. The role of potentially preventable hospital exposures in the development of acute respiratory distress syndrome: a population-based study. Crit Care Med. 2014;42:31–9. https://doi.org/10.1097/CCM.0b013e318298a6db.
Peters AL, Van Stein D, Vlaar APJ. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention. Br J Haematol. 2015;170:597–614. https://doi.org/10.1111/bjh.13459.
Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7):1757–67. https://doi.org/10.1182/blood-2011-08-370932.
Trillo-Alvarez C, Cartin-Ceba R, Kor DJ, et al. Acute lung injury prediction score: derivation and validation in a population-based sample. Eur Respir J. 2011;37:604–9. https://doi.org/10.1183/09031936.00036810.
Gajic O, Dabbagh O, Park PK, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med. 2011;183:462–70. https://doi.org/10.1164/rccm.201004-0549OC.
Festic E, Kor DJ, Gajic O. Prevention of ARDS. Curr Opin Crit Care. 2015;21:82–90. https://doi.org/10.1097/MCC.0000000000000174.
Li G, Malinchoc M, Cartin-Ceba R, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med. 2011;183:59–66. https://doi.org/10.1164/rccm.201003-0436OC.
Ferguson ND, Fan E, Luigi Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573–82. https://doi.org/10.1007/s00134-012-2682-1.
Fuchs L, Feng M, Novack V, et al. The effect of ARDS on survival: do patients die from ARDS or with ARDS? J Intensive Care Med. 2017;34:374–82.
Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8. https://doi.org/10.1056/NEJM200005043421801.
Brower RG, Lanken PN, MacIntyre N, et al. National Heart, Lung, and Blood Institute ARDS clinical trials network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327–36. https://doi.org/10.1056/NEJMoa032193.
Meade MO, Cook DJ, Guyatt GH, et al. Lung open ventilation study investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299:637–45. https://doi.org/10.1001/jama.299.6.637.
Mercat A, Richard JC, Vielle B, Expiratory Pressure (Express) Study Group, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299:646–55. https://doi.org/10.1001/jama.299.6.646.
Talmor D, Sarge T, Malhotra A, et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008;359:2095–104. https://doi.org/10.1056/NEJMoa0708638.
Walkey AJ, Del Sorbo L, Hodgson CL, et al. Higher PEEP versus lower PEEP strategies for patients with acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(Supplement_4):S297–303. https://doi.org/10.1513/AnnalsATS.201704-338OT.
Guo L, Xie J, Huang Y, et al. Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18:172. https://doi.org/10.1186/s12871-018-0631-4.
Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318:1335–45. https://doi.org/10.1001/jama.2017.14171.
Pensier J, de Jong A, Hajjej Z, et al. Effect of lung recruitment maneuver on oxygenation, physiological parameters and mortality in acute respiratory distress syndrome patients: a systematic review and meta-analysis. Intensive Care Med. 2019;45:1691–702. https://doi.org/10.1007/s00134-019-05821-9.
Sud S, Friedrich JO, Adhikari NKJ, et al. Effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ. 2014;186:E381–90. https://doi.org/10.1503/cmaj.140081.
Munshi L, Del Sorbo L, Adhikari NKJ, et al. Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14:S280–8. https://doi.org/10.1513/AnnalsATS.201704-343OT.
Aoyama H, Uchida K, Aoyama K, et al. Assessment of therapeutic interventions and lung protective ventilation in patients with moderate to severe acute respiratory distress syndrome: a systematic review and network meta-analysis. JAMA Netw Open. 2019;2:e198116. https://doi.org/10.1001/jamanetworkopen.2019.8116.
Combes A, Peek GJ, Hajage D, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46:2048–57. https://doi.org/10.1007/s00134-020-06248-3.
Chang W, Sun Q, Peng F, et al. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Crit Care. 2020;24:54. https://doi.org/10.1186/s13054-020-2765-2.
Tarazan N, Alshehri M, Sharif S, et al. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials. Intensive Care Med Exp. 2020;8:61. https://doi.org/10.1186/s40635-020-00348-6.
Ho ATN, Patolia S, Guervilly C. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. J Intensive Care. 2020;8:12. https://doi.org/10.1186/s40560-020-0431-z.
Abel SJ, Finney SJ, Brett SJ, et al. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax. 1998;53:292–4. https://doi.org/10.1136/thx.53.4.292.
Milberg JA, Davis DR, Steinberg KP, et al. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993. JAMA. 1995;273:306–9.
Stapleton RD, Wang BM, Hudson LD, et al. Causes and timing of death in patients with ARDS. Chest. 2005;128:525–32. https://doi.org/10.1378/chest.128.2.525.
Spragg RG, Bernard GR, Checkley W, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med. 2010;181:1121–7. https://doi.org/10.1164/rccm.201001-0024WS.
Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008;133:1120–7. https://doi.org/10.1378/chest.07-2134.
Erickson SE, Martin GS, Davis JL, et al. NIH NHLBI ARDS network. Recent trends in acute lung injury mortality: 1996–2005. Crit Care Med. 2009;37:1574–9. https://doi.org/10.1097/CCM.0b013e31819fefdf.
Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med. 2009;179:220–7. https://doi.org/10.1164/rccm.200805-722OC.
McNicholas BA, Rooney GM, Laffey JG, JG. Lessons to learn from epidemiologic studies in ARDS. Curr Opin Crit Care. 2018;24:41–8. https://doi.org/10.1097/MCC.0000000000000473.
Raymondos K, Dirks T, Quintel M, et al. Outcome of acute respiratory distress syndrome in university and non-university hospitals in Germany. Crit Care. 2017;21:122. https://doi.org/10.1186/s13054-017-1687-0.
Laffey JG, Bellani G, Pham T, et al. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2016;42(12):1865–76. https://doi.org/10.1007/s00134-016-4571-5.
Laffey JG, Bellani G, Kurahashi K, et al. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017;5:627–38.
Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979–1996). Crit Care Med. 2002;30:1679–85. https://doi.org/10.1097/00003246-200208000-00001.
Cochi SE, Kempker JA, Annangi S, et al. Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013. Ann Am Thorac Soc. 2016;13:1742–51. https://doi.org/10.1513/AnnalsATS.201512-841OC.
Erickson SE, Shlipak MG, Martin GS, et al. Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med. 2009;37:1–6. https://doi.org/10.1097/CCM.0b013e31819292ea.
Parcha V, Kalra R, Bhatt SP, et al. Trends and geographic variation in acute respiratory failure and ARDS mortality in the United States. Chest. 2021;159(4):1460–72. https://doi.org/10.1016/j.chest.2020.10.042.
Ryb GE, Cooper C. Race/ethnicity and acute respiratory distress syndrome: a National Trauma Data Bank study. J Natl Med Assoc. 2010;102:865–9. https://doi.org/10.1016/s0027-9684(15)30700-8.
Meyer NJ, Christie JD. Genetic heterogeneity and risk of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2013;34:459–74. https://doi.org/10.1055/s-0033-1351121.
Reilly JP, Christie JD, Meyer NJ, et al. Fifty years of research in ARDS. Genomic contributions and opportunities. Am J Respir Crit Care Med. 2017;196(9):1113–21. https://doi.org/10.1164/rccm.201702-0405CP.
Wei Y, Wang Z, Su L, et al. Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk. Chest. 2015;147:607–17. https://doi.org/10.1378/chest.14-1246.
Wei Y, Tejera P, Wang Z, et al. A missense genetic variant in LRRC16A/CARMIL1 improves acute respiratory distress syndrome survival by attenuating platelet count decline. Am J Respir Crit Care Med. 2017;195:1353–61. https://doi.org/10.1164/rccm.201605-0946OC.
Meyer NJ, Feng R, Li M, et al. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med. 2013;187:950–9. https://doi.org/10.1164/rccm.201208-1501OC.
Su L, Zhai R, Sheu CC, et al. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med. 2009;35:1024–30. https://doi.org/10.1007/s00134-009-1413-8.
Meyer NJ, Li M, Feng R, et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med. 2011;183:1344–53. https://doi.org/10.1164/rccm.201005-0701OC.
Reilly JP, Wang F, Jones TK, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Intensive Care Med. 2018;44:1849–58. https://doi.org/10.1007/s00134-018-5328-0.
Adhikari NKJ, Burns KEA, Friedrich JO, et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007;334:779. https://doi.org/10.1136/bmj.39139.716794.55.
Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683–93. https://doi.org/10.1056/NEJMoa022450.
Brown SM, Wilson EL, Presson AP, et al. Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes. Thorax. 2017;72:1094–103. https://doi.org/10.1136/thoraxjnl-2017-210337.
Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–304. https://doi.org/10.1056/NEJMoa1011802.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kurahashi, K. (2022). Epidemiology and Risk Factors of ARDS: How Many Is the Real Incidence of ARDS?. In: Tasaka, S. (eds) Acute Respiratory Distress Syndrome. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-16-8371-8_2
Download citation
DOI: https://doi.org/10.1007/978-981-16-8371-8_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-8370-1
Online ISBN: 978-981-16-8371-8
eBook Packages: MedicineMedicine (R0)